GlassScriptPhysician profile
Jagraj S Rai
NPI 1437220084
$3,560.97
in general payments reported to CMS, 2019-2025
18 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956 · 2020: $113 · 2021: $161 · 2022: $304 · 2023: $794 · 2024: $716 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,207.66 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $752.16 | 2019-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $329.06 | 2019-2023 | Arexvy |
| Novo Nordisk INC | $225.81 | 2019-2025 | Wegovy |
| Pfizer INC. | $214.74 | 2019-2020 | |
| Astellas Pharma US INC | $168.63 | 2019 | |
| Abbott Laboratories | $144.09 | 2019-2022 | |
| Intuitive Surgical, INC. | $140.00 | 2023 | Da Vinci Surgical System |
| Takeda Pharmaceuticals U.S.A., INC. | $89.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $73.45 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.88 | 2019 | |
| Lilly USA, LLC | $39.15 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.10 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $34.46 | 2019 | |
| Allergan, INC. | $19.43 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.06 | 2019 | |
| Amgen INC. | $16.14 | 2019 | |
| Merck Sharp & Dohme LLC | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagraj Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.